Market Place
Sourcing Support
HARMONY BIOSCIENCES Acknowledges FDA Action on WAKIX® Citizen Petition
25 Jun 2024 //
PR NEWSWIRE
Harmony Receives FDA Approval For WAKIX® (Pitolisant) In Pediatric Narcolepsy
24 Jun 2024 //
PR NEWSWIRE
Harmony Bio Initiates Ph 3 of Pitolisant in Patients with Prader-Willi Syndrome
03 Apr 2024 //
PR NEWSWIRE
Harmony Biosciences Receives FDA Orphan Drug Designation For Pitolisant
20 Feb 2024 //
PR NEWSWIRE
Harmony Announces Positive Data From Phase 2 Study Evaluating Pitolisant
07 Dec 2023 //
PR NEWSWIRE
Harmony Bio Announces Topline Data From Phase 3 Study Evaluating Pitolisant
13 Oct 2023 //
PR NEWSWIRE
Harmony Biosciences Announces FDA Orphan Drug Designation For Pitolisant
07 Sep 2023 //
PR NEWSWIRE
HARMONY BIOSCIENCES REITERATES CONFIDENCE IN WAKIX® (PITOLISANT) PATENTS
28 Aug 2023 //
PR NEWSWIRE
Harmony Bio Announces Plans To Initiate Piii Registrational Study Of Pitolisant
20 Jul 2023 //
PR NEWSWIRE
China NMPA approves RareStone`s pitolisant for the treatment of narcolepsy
04 Jul 2023 //
PR NEWSWIRE
Harmony Announces Positive Phase 2 Signal Detection Study Evaluating Pitolisant
06 Jun 2023 //
PR NEWSWIRE
Bioprojet: WAKIX receives approval for the treatment of narcolepsy
15 Mar 2023 //
PR NEWSWIRE
Harmony reports positive data from Phase II Prader-Willi syndrome trial
02 Nov 2022 //
CLINICALTRIALSARENA
Harmony Biosciences Reports Second Quarter 2022 Financial
02 Aug 2022 //
PRESS RELEASE
Harmony Biosciences Presents Post-Hoc Analysis Of Wakix Pivotal Data
06 Jun 2022 //
PRNEWSWIRE
Harmony begins Phase III idiopathic hypersomnia treatment trial
28 Apr 2022 //
CLINICALTRIALSARENA
EMA nod for excessive daytime sleepiness med Ozawade
28 Oct 2021 //
PHARMATIMES
Harmony Biosciences Announces Inclusion Of WAKIX® (pitolisant)
02 Sep 2021 //
PRNEWSWIRE
Bioprojet`s Ozawade (pitolisant) Receives Approval in Europe
01 Sep 2021 //
EMA
Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety
27 Apr 2021 //
PRNEWSWIRE
Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data
27 Apr 2021 //
PRNEWSWIRE
Harmony Biosciences To Present WAKIX® (Pitolisant) Data At The 2021 AAN
13 Apr 2021 //
PRNESWIRE
Harmony To Present WAKIX® (Pitolisant) Data At The 2021 AAN Annual Meeting
13 Apr 2021 //
PRNESWIRE
FDA Approvals Roundup: Inmazeb, Wakix, Venclexta
21 Oct 2020 //
RAPS
Harmony’s sleep disorder drug Wakix gets US label extension
14 Oct 2020 //
PHARMAPHORUM
Harmony Biosciences Presents Efficacy And Safety Analyses For WAKIX®
27 Aug 2020 //
PRNEWSWIRE
Harmony Biosciences To Present New Data For WAKIX® (pitolisant) At SLEEP 2020
24 Aug 2020 //
PRNEWSWIRE
Harmony Biosciences To Present New Data For WAKIX® (pitolisant) At SLEEP 2020
24 Aug 2020 //
PRNEWSWIRE
Pitolisant for Daytime Sleepiness in Patients Obstructive Sleep Apnea Who Refuse
12 Aug 2020 //
NCBI
WAKIX® (pitolisant) Data From Harmony Biosciences Included on American Academy
02 Jun 2020 //
PRNEWSWIRE
Following FDA approval, Wakix will gain a small share in narcolepsy market
20 Aug 2019 //
BIOSPECTRUMASIA
Harmony Biosciences scores first approval in narcolepsy med Wakix
15 Aug 2019 //
FIERCE PHARMA
Harmony Biosciences Announces FDA Approval Of WAKIX® (Pitolisant)
15 Aug 2019 //
PR NEWSWIRE
Harmony Biosciences Makes Headway on Narcolepsy Drug Involving Histamine
21 Jun 2018 //
BIOSPACE
Pitolisant Receives FDA Breakthrough Therapy and Fast Track Designations
21 May 2018 //
RAREDR
